Barbro Dahlén - Concepedia

Author

Barbro Dahlén

Karolinska Institutet ORCID

Also Known As

B Dahlen, B Dahln, B Dahlén, B. DAHLÉN, B. Dahlen, B. Dahlèn, B. Dahlén, BARBRO DAHLEN, BARBRO DAHLÉN, Barbro Dahlen

311

Publications

17.5K

Citations

H-Index

101

Concepts

All Affiliations

Karolinska Institutet Karolinska University Hospital University of Amsterdam Imperial College London Umeå University

About

Barbro Dahlén is an author at Karolinska Institutet specializing in medicine, asthma, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	47	3.8K
2	Health Sciences	5	5	199
3	Public Health	3	3	126
4	Natural Sciences	2	2	74
5	Engineering	1	1	62

Barbro Dahlén

115

Publications

Citations

H-Index

Page 1

	Year	Citations
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort Dominick Shaw, Ana R. Sousa, Stephen J. Fowler, European Respiratory Journal	2015	548
Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4. Sven‐Erik Dahlén, Göran K. Hansson, Per Hedqvist, Proceedings of the National Academy of Sciences AsthmaEnvironmental AllergyInflammatory Lung DiseaseLung InflammationImmunology	1983	420
Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics Barbro Dahlén, Ewa Niżankowska, A Szczeklik, American Journal of Respiratory and Critical Care Medicine	1998	395
Improvement of Aspirin-Intolerant Asthma by Montelukast, a Leukotriene Antagonist Sven‐Erik Dahlén, Kerstin Malmström, Ewa Niżankowska, American Journal of Respiratory and Critical Care Medicine InflammationAsthmaAnti-inflammatoryAllergyAspirin-intolerant Asthma	2002	317
Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. A. Roquet, Barbro Dahlén, Maria Kumlin, American Journal of Respiratory and Critical Care Medicine AsthmaInflammationEnvironmental AllergyAllergyLung Inflammation	1997	310
Urinary Excretion of Leukotriene E <sub>4</sub> and 11-dehydro-Thromboxane B <sub>2</sub> in Response to Bronchial Provocations with Allergen, Aspirin, Leukotriene D <sub>4</sub> , and Histamine in Asthmatics Maria Kumlin, Barbro Dahlén, T Björck, American Review of Respiratory Disease	1992	289
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics Diane Lefaudeux, Bertrand De Meulder, Matthew J. Loza, Journal of Allergy and Clinical Immunology AsthmaAllergySputum OmicsMulti-omics StudyImmunology	2016	281
A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED Chih‐Hsi S. Kuo, Stelios Pavlidis, Matthew J. Loza, American Journal of Respiratory and Critical Care Medicine	2016	199
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation Zala Jevnikar, Jörgen Östling, Elisabeth Ax, Journal of Allergy and Clinical Immunology	2018	187
The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics Barbro Dahlén, Maria Kumlin, DJ Margolskee, European Respiratory Journal AsthmaInflammationMolecular PharmacologyAnti-inflammatoryAllergy	1993	176

Page 1